Catalog #BE0231FAB

InVivoMAb anti-human CD3 F(ab) fragment

Clone UCHT1 (Leu-4) (T3) f(ab) Fragments
Reactivities Human
Isotype Mouse IgG1, κ

$560.00 - $7,581.50

$560.00 - $7.00

Choose an Option...
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

This product is an F(ab) fragment derived from the anti-human CD3 antibody clone UCHT1 (Leu-4) (T3). The UCHT1 (Leu-4) (T3) monoclonal antibody reacts with human CD3ε, a 20 kDa transmembrane cell-surface protein and member of the immunoglobulin superfamily. CD3ε is one of the polypeptide chains that associates with the T cell receptor (TCR) to form the TCR/CD3 complex. CD3ε is expressed on T lymphocytes, NK-T cells, and to varying degrees on developing thymocytes, where it plays a central role in TCR signaling, T cell activation, and antigen recognition. Unlike a full-length antibody, this F(ab) fragment contains only the antigen-binding region and lacks the Fc domain. As a result, the fragment retains specific binding to human CD3ε while eliminating Fc-mediated effector functions such as complement activation and Fc receptor engagement. Because the Fc region is absent, this format is useful in experiments where CD3 engagement or T cell targeting is desired without Fc-dependent immune effects, including antibody-mediated cytotoxicity, Fc receptor–driven cross-linking by accessory cells, or complement activation. Immobilized full-length UCHT1 (Leu-4) (T3) antibody is commonly used to activate human T cells in vitro through crosslinking of the TCR/CD3 complex. In contrast, the F(ab) fragment format may provide a more controlled approach for studies focused on CD3 binding, receptor engagement, or T cell targeting while minimizing secondary Fc-mediated mechanisms that can complicate interpretation of results. This can be particularly useful when researchers want to examine CD3-associated biology without introducing Fc-dependent immune activation. F(ab) fragments targeting CD3 may also be useful in emerging targeted delivery and cell-engineering strategies. For example, CD3-binding fragments can be used to coat nanoparticles, viral vectors, or other delivery systems to selectively target T cells and deliver genetic payloads such as CAR constructs or gene-editing components directly in vivo. By avoiding Fc-mediated immune interactions, F(ab) fragments help preserve target cells while enabling receptor-specific targeting and delivery. This anti-human CD3 F(ab) fragment therefore provides a useful reagent for studies focused on human T cell targeting, CD3 engagement without Fc-mediated effects, and receptor-directed delivery approaches.

Specifications

Isotype Mouse IgG1, κ
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Human CD3ε
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤1EU/mg (≤0.001EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE and SEC
Sterility 0.2 µm filtration
Production Papain Digest
Purification Protein G
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Related Products

  1. Catalog #BE0231
    InVivoMAb anti-human CD3 Read more
  2. Catalog #BE0002
    InVivoMAb anti-mouse CD3 Read more
  3. Catalog #BE0001-2
    InVivoMAb anti-human CD3 Read more
  4. Catalog #CP083
    RecombiMAb anti-mouse CD3ε (LALA-PG) Read more
  5. Catalog #CP082
    RecombiMAb anti-mouse CD3ε Read more
  6. Catalog #BE0001-2FAB
    InVivoMAb anti-human CD3 F(ab) fragment Read more
  7. Catalog #BE0002FAB
    InVivoMAb anti-mouse CD3 F(ab) fragment Read more
  8. Catalog #CPB519
    Bispecific anti-mouse CD3 x anti-mouse/human TRP1 (LALA-PG) - PREORDER Read more